(Q64961173)

1 July 2019

title

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). (English)

1 reference

1 July 2019

main subject

Clostridium difficile

object named as

Clostridium difficile

1 reference

10

Roger Baxter

1 reference

1 July 2019

author name string

Brett A Leav

1

1 reference

1 July 2019

Barbra Blair

2

1 reference

1 July 2019

Mark Leney

3

1 reference

1 July 2019

Michael Knauber

4

1 reference

1 July 2019

Courtney Reilly

5

1 reference

1 July 2019

Israel Lowy

6

1 reference

1 July 2019

Dale N Gerding

7

1 reference

1 July 2019

Ciarán P Kelly

8

1 reference

1 July 2019

Kia Katchar

9

1 reference

1 July 2019

Donna Ambrosino

11

1 reference

1 July 2019

Deborah Molrine

12

1 reference

1 July 2019

language of work or name

English

0 references

publication date

24 November 2009

1 reference

1 July 2019

number of pages

5

1 reference

inferred from page(s)

published in

Vaccine

1 reference

1 July 2019

volume

28

1 reference

1 July 2019

issue

4

1 reference

1 July 2019

page(s)

965-969

1 reference

1 July 2019

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

An epidemic, toxin gene-variant strain of Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Serum antibody response to toxins A and B of Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-rep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Toxin B is essential for virulence of Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

7 January 2021

inferred from DOI database lookup

Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

7 January 2021

inferred from DOI database lookup

Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.144

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2009.10.144

1 reference

1 July 2019

PubMed ID

19941990

1 reference

1 July 2019